Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Non Operating Income (2016 - 2025)

Kiora Pharmaceuticals' Non Operating Income history spans 11 years, with the latest figure at -$730447.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 854.62% year-over-year to -$730447.0; the TTM value through Dec 2025 reached -$436906.0, down 1775.7%, while the annual FY2025 figure was -$160272.0, 714.7% down from the prior year.
  • Non Operating Income reached -$730447.0 in Q4 2025 per KPRX's latest filing, down from $178114.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $276489.0 in Q2 2021 to a low of -$730447.0 in Q4 2025.
  • Average Non Operating Income over 5 years is -$1412.3, with a median of $937.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: soared 11182.28% in 2023, then plummeted 854.62% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$3832.0 in 2021, then skyrocketed by 124.45% to $937.0 in 2022, then crashed by 6464.78% to -$59638.0 in 2023, then soared by 262.31% to $96797.0 in 2024, then tumbled by 854.62% to -$730447.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Non Operating Income are -$730447.0 (Q4 2025), $178114.0 (Q3 2025), and $131680.0 (Q2 2025).